irinotecan has been researched along with Colitis Gravis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, Z; Chen, L; Chen, S; Chen, Y; Huang, W; Jiao, S; Li, Z; Liu, Y; Sun, L; Wang, W; Yang, Z; Zhang, L | 1 |
| Cohen, D; Ghaffaripour, T; Stoner, P | 1 |
2 other study(ies) available for irinotecan and Colitis Gravis
| Article | Year |
|---|---|
Discovery of novel carboxylesterase 2 inhibitors for the treatment of delayed diarrhea and ulcerative colitis.
Topics: Camptothecin; Carboxylesterase; Colitis, Ulcerative; Diarrhea; Humans; Intestines; Irinotecan; Structure-Activity Relationship | 2023 |
Aggressive large-cell neuroendocrine carcinoma of the sigmoid colon in a patient with ulcerative colitis.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Camptothecin; Carcinoma, Neuroendocrine; Colitis, Ulcerative; Fatal Outcome; Female; Humans; Irinotecan; Leucovorin; Liver Neoplasms; Precancerous Conditions; Risk Factors; Sigmoid Neoplasms; Tomography, X-Ray Computed | 2017 |